Remote Working May Help Delay Retirement Of Senior US FDA Officials
CBER director Peter Marks notes efforts to bring in more staff to deal with ‘crushing’ workload; says there has been no political pressure for the center to approve COVID-19 booster shots.
You may also be interested in...
CBER Director Peter Marks said the FDA’s remote and in-person work system is functioning well and continues to help recruitment.
The new job notice offers a top salary, but also invites questions about the candidate pool attracted by the original solicitation.
US FDA has not named permanent heads of several offices within the new Office of Therapeutic Products, the only super office in the Center for Biologics Evaluation and Research.